Top-News

OWC PHARMACEUTICAL RESH CORP News

Aktie
WKN:  ISIN:  US67109N1081 US-Symbol:  OWCP
-    $
+0,00 $
0,00%
17.05.24 15:30:00
Handeln Depot/Watchlist
Aktienanzahl *
-
Marktkapitalisierung *
-
Streubesitz
-
Index-Zugehörigkeit
-

OWC PHARMACEUTICAL RESH CORP News

14.09.20 - PR Newswire
OWC Pharmaceutical Research Corp. Announces A New Distribution Agreement With Can It Industries, Florida US
OWC Pharmaceutical Research Corp. Announces A New Distribution Agreement With Can It Industries, Florida US Can It Industries, FL, will provide OWC with its distribution ...
19.08.20 - PR Newswire
OWC Pharmaceutical Research Corp. Letter to Shareholders for Upcoming Proxy Voting
OWC Pharmaceutical Research Corp. Letter to Shareholders for Upcoming Proxy Voting Shareholders meeting is set for Aug 31st, 2020. The proxy includes proposals for a reverse ...
29.07.20 - PR Newswire
OWC Pharmaceutical Research Corp. Announces Special Meeting of Stockholders
OWC Pharmaceutical Research Corp. Announces Special Meeting of Stockholders Meeting tentatively scheduled for August 25, 2020 The USPTO recently awarded the company a ...
16.12.19 - PR Newswire
OWC Israel's Patent for Cannabis Based Extracts and Topical Formulations for Use in Skin Disorders, Is Allowed for Issuance as a Patent in the USA
OWC Israel's Patent for Cannabis Based Extracts and Topical Formulations for Use in Skin Disorders, Is Allowed for Issuance as a Patent in the USA PR Newswire
14.11.19 - PR Newswire
OWC Pharmaceutical Research Corp and STENOCARE to Enter Partnership to Develop Advanced Medical Cannabis Products
OWC Pharmaceutical Research Corp and STENOCARE to Enter Partnership to Develop Advanced Medical Cannabis Products PR Newswire
07.10.19 - PR Newswire
OWC Pharmaceutical Research Corp. to Report Top Line Results (TLR) for a Safety Study on Its Cannabis-based Tablets
OWC Pharmaceutical Research Corp. to Report Top Line Results (TLR) for a Safety Study on Its Cannabis-​based Tablets PR Newswire
05.08.19 - PR Newswire
OWC Pharmaceutical Research Received a Permit for a Cannabis Based Ointment Efficacy Trial
OWC Pharmaceutical Research Received a Permit for a Cannabis Based Ointment Efficacy Trial PR Newswire
13.03.19 - PR Newswire
OTC Markets Group Announces Gold Sponsorship of 31st Annual ROTH Conference
OTC Markets Group Announces Gold Sponsorship of 31st Annual ROTH Conference OTCQX and OTCQB Companies Featured at 2019 ROTH Conference PR Newswire
11.02.19 - PR Newswire
OWC Pharmaceutical Research Corp, Letter to Shareholders
OWC Pharmaceutical Research Corp, Letter to Shareholders PR Newswire
30.01.19 - PR Newswire
OWC Pharmaceutical Research Corp. Reports Positive Safety Data From Phase 1 (Safety) Clinical Trial for Medical Grade Cannabis Ointment for Treatment of Skin Diseases
OWC Pharmaceutical Research Corp. Reports Positive Safety Data From Phase 1 (Safety) Clinical Trial for Medical Grade Cannabis Ointment for Treatment of Skin Diseases PR ...
31.12.18 - PR Newswire
OWC Pharmaceutical Research Corp. to Report Progress on Ointment Care for Skin Diseases
OWC Pharmaceutical Research Corp. to Report Progress on Ointment Care for Skin Diseases PR Newswire
27.12.18 - PR Newswire
OWC Pharmaceutical Research Corp. to Attend Biotech Showcase 2019
OWC Pharmaceutical Research Corp. to Attend Biotech Showcase 2019 PR Newswire
18.12.18 - PR Newswire
OWC Pharmaceutical Research Corp. Reports the Successful Production of Its Cannabinoid-Enriched Sublingual Disintegrating Tablet
OWC Pharmaceutical Research Corp. Reports the Successful Production of Its Cannabinoid-​Enriched Sublingual Disintegrating Tablet PR Newswire
29.11.18 - PR Newswire
OWC Pharmaceutical Research Corp Reports Progress in Clinical Trials for Ointment Care for Skin Diseases
OWC Pharmaceutical Research Corp Reports Progress in Clinical Trials for Ointment Care for Skin Diseases PR Newswire
29.11.18 - PR Newswire
OWC Pharmaceutical Research Corp. to Report Progress in Clinical Trials for Ointment Care for Skin Diseases
OWC Pharmaceutical Research Corp. to Report Progress in Clinical Trials for Ointment Care for Skin Diseases PR Newswire
08.11.18 - PR Newswire
OWC Pharmaceutical Research Corp. plant Treffen mit Investoren, Wissenschaftlern und Geschäftspartnern im Rahmen der 2018 MJBizCon; neue Verabreichungsform zur Therapie von multiplen Myelomen in der Testphase
OWC Pharmaceutical Research Corp. plant Treffen mit Investoren, Wissenschaftlern und Geschäftspartnern im Rahmen der 2018 MJBizCon; neue Verabreichungsform zur ...
07.11.18 - PR Newswire
OWC Pharmaceutical Research Corp. plant Treffen mit Investoren, Wissenschaftlern und Geschäftspartnern im Rahmen der 2018 MJBizCon; neue Verabreichungsform zur Therapie von multiplen Myelomen in der Testphase
OWC Pharmaceutical Research Corp. plant Treffen mit Investoren, Wissenschaftlern und Geschäftspartnern im Rahmen der 2018 MJBizCon; neue Verabreichungsform zur ...
06.11.18 - PR Newswire
OWC Pharmaceutical Research Corp. to Meet With Investors, Researchers and Business Partners at 2018 MJBizCon; Revealing the Testing of Novel Formulation for Multiple Myeloma Therapy
OWC Pharmaceutical Research Corp. to Meet With Investors, Researchers and Business Partners at 2018 MJBizCon; Revealing the Testing of Novel Formulation for Multiple ...
06.11.18 - PR Newswire
OWC Pharmaceutical Research Corp. to Meet With Investors, Researchers and Business Partners at 2018 MJBizCon; Revealing the Testing of Novel Formulation for Multiple Myeloma Therapy
OWC Pharmaceutical Research Corp. to Meet With Investors, Researchers and Business Partners at 2018 MJBizCon; Revealing the Testing of Novel Formulation for Multiple ...
06.11.18 - PR Newswire
OWC Pharmaceutical Research Corp. to Meet With Investors, Researchers and Business Partners at 2018 MJBizCon; Revealing the Testing of Novel Formulation for Multiple Myeloma Therapy
OWC Pharmaceutical Research Corp. to Meet With Investors, Researchers and Business Partners at 2018 MJBizCon; Revealing the Testing of Novel Formulation for Multiple ...

Newssuche

Videos

newspaper
17.05.24 +14,15%
Technical Trading: Gold Long-​Chance
Gold Long Typ: Turbo Open End WKN: VD1G7Y Hebel: 10 Laufzeit: OpenEnd Einstieg: Market ... Mehr »